This is inflammation, or swelling, of an artery. It's like an infection or irritation affecting the artery's walls.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Arteritis?
Arteritis means inflammation of the arteries, the vessels that carry blood from the heart to the rest of the body. It is a type of vasculitis, a group of conditions in which the immune system mistakenly attacks blood vessel walls. An inflamed artery can narrow or close, reducing blood flow to the tissues it supplies, or its wall can weaken and bulge into an aneurysm. What a person notices depends on which arteries are involved. Two forms account for most cases. Giant cell arteritis, also called temporal arteritis, affects adults over 50, most often around age 70. It typically involves arteries of the head and scalp, causing a new headache, tenderness over the temples, jaw pain when chewing and sometimes sudden vision loss, and it can also reach the aorta and arteries to the arms. Takayasu arteritis is rare and usually begins in women under 40. It inflames the aorta and its main branches, which can leave pulses in the arms weak or absent. Arteritis can also occur alongside an infection or another disease, or as a reaction to a medicine.
The exact cause of giant cell arteritis and Takayasu arteritis is not known. Both are immune-driven, and researchers suspect a combination of inherited susceptibility and an outside trigger, such as an infection, though no specific trigger has been proven. For giant cell arteritis, age is the strongest risk factor: it almost never occurs before 50. It is about twice as common in women as in men and more common in people of Northern European ancestry. It is closely linked with polymyalgia rheumatica, a condition that causes aching and stiffness in the shoulders, neck and hips. About half of people with giant cell arteritis have polymyalgia symptoms, and some people with polymyalgia later develop giant cell arteritis. Takayasu arteritis affects women far more often than men and appears to be more common in people of Asian descent.
No single blood test confirms arteritis. Blood tests for inflammation, such as the erythrocyte sedimentation rate (ESR, or sed rate) and C-reactive protein (CRP), are usually raised during active disease, and normal results make giant cell arteritis less likely. Raised results show inflammation somewhere in the body but do not say where it is coming from. For suspected giant cell arteritis, a clinician asks about headache, jaw pain and vision changes and feels the arteries at the temples, which may be tender, thickened or pulseless. In the United States, the diagnosis is usually confirmed with a temporal artery biopsy, in which a short piece of the artery at the temple is removed under local anesthetic and examined for inflammation. The biopsy is best done within about two weeks of starting steroids, because treatment gradually erases the signs, but steroids should not be delayed to wait for it. Some centers use ultrasound of the temple arteries instead. After diagnosis, imaging of the aorta and its branches can show whether larger arteries are involved. Takayasu arteritis is diagnosed mainly with imaging. CT or MR angiography (detailed scans of the blood vessels) shows narrowing, blockage or widening of the aorta and its branches. A clinician may also find a weak or missing pulse, a large difference in blood pressure between the two arms, or a whooshing sound over an artery heard with a stethoscope. Because early symptoms are vague, Takayasu arteritis is often recognized only after years of fatigue, fever or aches.
Treatment aims to stop the inflammation quickly and then keep it controlled with as little steroid exposure as possible. Steroids (glucocorticoids such as prednisone) work fast and remain the foundation of treatment for both main forms. They are started at a high dose, often before a biopsy result is back when giant cell arteritis is suspected, because they protect vision. Headaches and other symptoms often ease within days. The dose is then lowered gradually over months, and many people with giant cell arteritis come off steroids within one to two years, although some need them longer. Pulses of steroids given through a vein may be used when vision is already threatened. Because long courses of steroids can cause bone thinning, weight gain, poor sleep, mood changes, muscle weakness and cataracts, doctors often add a steroid-sparing medicine. For giant cell arteritis, tocilizumab (Actemra), an injected biologic that blocks the inflammatory signal interleukin-6, helps people reduce steroids and stay in remission. It raises the risk of serious infections, and it can keep inflammation blood tests low even during a flare, so follow-up relies on symptoms and examination. Upadacitinib (Rinvoq), a daily tablet in the JAK inhibitor family, is also approved for giant cell arteritis. Methotrexate, an older immune-suppressing medicine, is an option when these are unsuitable, though its steroid-sparing effect is smaller. For Takayasu arteritis, steroids are usually combined from the start with methotrexate, azathioprine or a TNF inhibitor, a type of biologic that blocks a different inflammatory signal. Tocilizumab is generally reserved for people who do not respond to these. Narrowed arteries often develop natural detours (collateral circulation) over time, so surgery or stenting is usually saved for serious problems, such as an aneurysm at risk of rupture or loss of blood flow to an organ or limb, and is best done when the inflammation is controlled. Low-dose aspirin may be added when arteries supplying the brain are severely narrowed, and blood pressure treatment is important when a kidney artery is involved.
With prompt treatment, most people with giant cell arteritis feel much better within days, and vision that has not yet been affected is usually protected. Vision already lost before treatment is often permanent. The illness can return as steroids are lowered, so tapering is gradual and guided by symptoms and examination rather than by blood tests alone. Steroids should not be stopped suddenly unless the care team advises it, because the body comes to rely on them. Takayasu arteritis tends to be a longer-term condition that can smolder quietly and flare. Many people live active lives, but some have lasting effects from narrowed arteries, such as arm or leg pain with use, high blood pressure or heart valve problems. Regular imaging is part of care because arteries can change even when a person feels well. For both forms, long-term follow-up continues even in remission. Visits typically check symptoms, blood pressure in both arms, blood tests and, when needed, scans of the aorta to look for narrowing or an aneurysm. Living with long courses of steroids also means monitoring bone health, weight, mood and eyes, and many people are offered calcium, vitamin D or a bone-protecting medicine.
Book a prompt visit for ongoing fevers, fatigue and weight loss without explanation, or for arm or leg pain that comes on with use and eases with rest, particularly in a younger woman. Anyone over 50 with a new or different headache, tenderness at the temples or scalp, or jaw pain when chewing should be seen the same day, because suspected giant cell arteritis is treated before tests are complete. People already diagnosed should contact their care team quickly if these symptoms return while steroids are being lowered. Any sudden loss of vision, dimming or blurring in one eye, or new double vision in someone with these symptoms or a known diagnosis needs emergency care right away, because untreated giant cell arteritis can blind the other eye too. Sudden weakness on one side, trouble speaking or facial drooping can signal a stroke and needs a 911 call.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Arteritis is like, what's helped you, or ask the community a question.